4//SEC Filing
Kulkarni Shashikant 4
Accession 0001077183-22-000127
CIK 0001077183other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 5:44 PM ET
Size
8.3 KB
Accession
0001077183-22-000127
Insider Transaction Report
Form 4
Kulkarni Shashikant
President of Lab Operations
Transactions
- Award
Common Stock
2022-08-01+24,704→ 65,856 total - Award
Stock Option (Right to Buy)
2022-08-01+51,653→ 51,653 totalExercise: $10.12Exp: 2029-08-01→ Common Stock (51,653 underlying)
Holdings
- 88,496
Stock Option (Right to Buy)
Exercise: $12.15Exp: 2029-04-01→ Common Stock (88,496 underlying)
Footnotes (3)
- [F1]On August 1, 2022, Dr. Kulkarni was granted 24,704 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
- [F2]On April 1, 2022, Dr. Kulkarni was granted 88,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On August 1, 2022, Dr. Kulkarni was granted 51,653 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001936800
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 5:44 PM ET
- Size
- 8.3 KB